NEXIEN BIOPHARMA, INC. Stock-Based Compensation
NEXIEN BIOPHARMA, INC. reported Stock-Based Compensation of $348.95 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2022-09-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-09-28
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2021-06-30 was -$218.50K.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2021-03-31 was $33.23K.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $286.08K, a 1741.02% increase year-over-year.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-09-30 was $248.14K, a 578.03% increase year-over-year.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $348.95K, a 569.30% increase from fiscal 2020.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $52.14K, a 97.25% decline from fiscal 2019.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $1.90M, a 295.08% increase from fiscal 2018.
- NEXIEN BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $480.35K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$218.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | -$185.27K derived: sum of 2 quarters · filed 2022-09-28 | $100.81K derived: sum of 3 quarters · filed 2022-09-28 | $348.95K 10-K · filed 2022-09-28 |
| 2021-03-31 | $33.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | $319.31K derived: sum of 2 quarters · filed 2022-05-12 | $567.45K 10-Q · filed 2022-05-12 | $567.45K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $286.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | $534.22K 10-Q · filed 2022-02-08 | $534.22K derived: sum of 3 quarters · filed 2022-02-08 | $534.22K derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-09-30 | $248.14K 10-Q · filed 2021-11-22 | $248.14K derived: sum of 2 quarters · filed 2021-11-22 | $248.14K derived: sum of 3 quarters · filed 2021-11-22 | $263.68K derived: sum of 4 quarters · filed 2021-11-22 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $0.00 derived: sum of 2 quarters · filed 2021-10-12 | $15.54K derived: sum of 3 quarters · filed 2021-10-12 | $52.14K 10-K · filed 2021-10-12 |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-05 | $15.54K derived: sum of 2 quarters · filed 2021-05-05 | $52.14K 10-Q · filed 2021-05-05 | $145.94K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $15.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $52.14K 10-Q · filed 2021-02-11 | $145.94K derived: sum of 3 quarters · filed 2021-02-11 | $367.57K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-09-30 | $36.60K 10-Q · filed 2020-11-10 | $130.40K derived: sum of 2 quarters · filed 2020-11-10 | $352.03K derived: sum of 3 quarters · filed 2020-11-10 | $1.35M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $93.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-28 | $315.44K derived: sum of 2 quarters · filed 2020-09-28 | $1.31M derived: sum of 3 quarters · filed 2020-09-28 | $1.90M 10-K · filed 2020-09-28 |
| 2019-03-31 | $221.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14 | $1.22M derived: sum of 2 quarters · filed 2020-05-14 | $1.80M 10-Q · filed 2020-05-14 | $1.85M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $994.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12 | $1.58M 10-Q · filed 2020-02-12 | $1.63M derived: sum of 3 quarters · filed 2020-02-12 | $1.67M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-09-30 | $587.72K 10-Q · filed 2019-11-12 | $633.55K derived: sum of 2 quarters · filed 2019-11-12 | $679.38K derived: sum of 3 quarters · filed 2019-11-12 | $782.95K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $45.83K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | $91.67K derived: sum of 2 quarters · filed 2019-09-30 | $195.23K derived: sum of 3 quarters · filed 2019-09-30 | $480.35K 10-K · filed 2019-09-30 |
| 2018-03-31 | $45.83K 10-Q · filed 2018-05-15 | $149.40K derived: sum of 2 quarters · filed 2018-05-15 | $434.52K 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $103.57K 10-Q · filed 2018-02-14 | $388.68K 10-Q · filed 2019-02-14 | ||
| 2017-09-30 | $285.12K 10-Q · filed 2018-11-14 |